Irinotecan (Iri) plus Docetaxel (Doc) Every 3 Weeks in Chemotherapy Naive Patients (Pts) with Inoperable Non-Small Cell Lung Cancer (Nsclc): Results of a Phase Ii Study
AuthID
P-000-C9B
P-000-C9B
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service